AQR Capital Management
TXMD icon

AQR Capital Management’s TherapeuticsMD TXMD Stock Holding History

AQR Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,645
Closed -$50K – 2303
2022
Q1 		$50K Sell
2,645
-2,817
-52% -$44.3K ﹤0.01% 2184
2021
Q4 		$97K Buy
5,462
+3,825
+234% +$115K ﹤0.01% 2152
2021
Q3 		$61K Buy
+1,637
New +$72.6K ﹤0.01% 2219
2021
Q1 		– Sell
-1,030
Closed -$62K – 2265
2020
Q4 		$62K Buy
+1,030
New +$70.3K ﹤0.01% 2173
2018
Q4 		– Sell
-600
Closed -$197K – 2279
2018
Q3 		$197K Buy
600
+158
+36% +$48.4K ﹤0.01% 2196
2018
Q2 		$138K Buy
+442
New +$135K ﹤0.01% 2269
2017
Q3 		– Sell
-538
Closed -$142K – 2284
2017
Q2 		$142K Hold
538
– – ﹤0.01% 2159
2017
Q1 		$194K Sell
538
-55
-9% -$17K ﹤0.01% 2116
2016
Q4 		$171K Sell
593
-764
-56% -$237K ﹤0.01% 2171
2016
Q3 		$462K Buy
1,357
+183
+16% +$66.8K ﹤0.01% 1969
2016
Q2 		$499K Sell
1,174
-326
-22% -$134K ﹤0.01% 1881
2016
Q1 		$480K Sell
1,500
-360
-19% -$123K ﹤0.01% 1852
2015
Q4 		$964K Sell
1,860
-857
-32% -$316K ﹤0.01% 1589
2015
Q3 		$796K Buy
2,717
+1,148
+73% +$408K ﹤0.01% 1548
2015
Q2 		$616K Buy
1,569
+1,321
+533% +$466K ﹤0.01% 1699
2015
Q1 		$75K Sell
248
-2,022
-89% -$494K ﹤0.01% 2105
2014
Q4 		$505K Sell
2,270
-1,034
-31% -$213K ﹤0.01% 1956
2014
Q3 		$767K Hold
3,304
– – ﹤0.01% 1746
2014
Q2 		$730K Sell
3,304
-2,716
-45% -$604K ﹤0.01% 1800
2014
Q1 		$1.9M Buy
6,020
+5,746
+2,097% +$1.83M 0.01% 1344
2013
Q4 		$71K Buy
+274
New +$60K ﹤0.01% 2538

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Capital Management's TXMD Position: Q2 2022 in Review

AQR Capital Management sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 2,645 shares — an estimated $50K sold.

AQR Capital Management first reported a position in TXMD in Q4 2013 and held it in 21 quarters. The position peaked at $1.9M in Q1 2014. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • AQR Capital Management reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • AQR Capital Management sold 2,645 TherapeuticsMD shares in Q2 2022, an estimated $50K.
  • AQR Capital Management first reported a position in TherapeuticsMD in Q4 2013 and held it in 21 quarters.
  • AQR Capital Management's TherapeuticsMD position peaked at $1.9M in Q1 2014.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.